Search for a research project
Other search option(s)
61 Result(s)
Funded by an IRDiRC member = 
Member of a ERN = 
Research projects
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Targets for heart regeneration : mechanisms controlling cardiomyocyte proliferation
Institution: Information not provided - FR
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Mechanosensitive ionic channels in zebrafish heart regeneration
Institution: Information not provided - FR
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Evaluation of FGF10 as a target for promoting adult cardiomyocyte proliferation after heart injury
Institution: Information not provided - FR
BELGIUM
VLAAMS BRABANT
LEUVEN
AMEND-CRT: Assessment of Mechanical Dyssynchrony as Selection Criterion for Cardiac Resynchronization Therapy
UZ Leuven - Campus Gasthuisberg
UZ Leuven - Gasthuisberg
FINLAND
Finland
TURKU
LMNA-related dilated cardiomyopathy: modelling and molecular targeting of cellular stress in vitro and in vivo
University of Turku
Institute of Biomedicine
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Role of Actin-SRF-MRTFA Axis in the development of dilated cardiomyopathy
Institution: Information not provided - FR
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Bcl11b/CTIP2, a transcriptional repressor: its role in cardiac homeostasis and remodeling
Institution: Information not provided - FR
FRANCE
ILE-DE-FRANCE
PARIS
Identification of genes and phenotype/genotype relations in arrythmogenic right vendricular dysplasia (ARVD)
APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière
Départements de génétique et de cardiologie - Centre de référence des maladies cardiaques héréditaires
FRANCE
ILE-DE-FRANCE
PARIS
Structural studies of cardiac myosin for therapeutical approaches against HCM
CLCC Institut Curie
Motilité structurale
GERMANY
Berlin
ADDRESS: NOT PROVIDED - DE
ERA-CVD - DETECTIN-HF : Determination of the role of clinical and epigenetic risk markers in dilated cardiomyopathy and heart failure
Institution: Information not provided - DE
JAPAN
JAPAN
TOKYO
Development of gene therapy for cardiac regeneration in dilated cardiomyopathy
Keio University School of Medicine
Department of Cardiology
JAPAN
JAPAN
TOKYO
Development of novel disease-causing gene based therapies for cardiomyopathies
Tokyo Medical and Dental University Medical Research Institute
SPAIN
Comunidad Valenciana
VALENCIA
Modulation of the arrhythmogenic myocardiopatia phenotype to improve the diagnosis, search for new treatments and understand its physiopathogenic mechanisms. Role of epicardic fat.
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de investigación en cardiopatías familiares, muerte súbita y mecasnismos de enfermedad
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Deciphering the potency of venricular trabeculae to repair the heart during cardiac regeneration in the mouse
Institution: Information not provided - FR
FRANCE
ILE-DE-FRANCE
PARIS
Identification of causative genes for familial dilated cardiomyopathies and of susceptibility genes for non familial forms of the disease
APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière
Physiopathologie, génétique et pharmacologie du remodelage cardiovasculaire
FRANCE
ILE-DE-FRANCE
PARIS
Identification of causative genes for familial dilated cardiomyopathies and of susceptibility genes for non familial forms of the disease
APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière
Départements de génétique et de cardiologie - Centre de référence des maladies cardiaques héréditaires
FRANCE
ILE-DE-FRANCE
PARIS
Identification of genes in myocardial noncompaction
APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière
Départements de génétique et de cardiologie - Centre de référence des maladies cardiaques héréditaires
GERMANY
Berlin
ADDRESS: NOT PROVIDED - DE
ERA-CVD - VARIATION: New RNA therapies for the treatment of cardiomyopathies caused by LMNA mutations
Institution: Information not provided - DE
GERMANY
Schleswig-Holstein
LÜBECK
The GErman Italian Spanish Takotsubo (GEIST) Registry
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Medizinische Klinik II - Kardiologie, Angiologie, Intensivmedizin
ITALY
LOMBARDIA
MILANO
Contribution of lipids and their oxidized metabolites on Arrhythmogenic Cardiomyopathy pathogenesis
Centro Cardiologico Monzino
Unità di Biologia vascolare e Medicina rigenerativa
ITALY
LOMBARDIA
MILANO
Contribution of lipids and their oxidized metabolites on Arrhythmogenic Cardiomyopathy pathogenesis
Università degli Studi di Milano - Scienze Farmacologiche e Biomolecolari
Laboratorio di Farmacologia Cellulare dell'Aterosclerosi
JAPAN
JAPAN
OSAKA
Investigation of inherited primary arrhythmia syndromes caused by RYR2 gene mutations including catecholaminergic polymorphic entricular tachycardia
National Cerebral and Cardiovascular Center
Department of Bioscience and Genetics
SPAIN
Asturias
OVIEDO
Reclassification of variants of uncertain significance in hypertrophic myocardiopatia: genetic variation in a cohort, control and analysis of the transcriptome
Hospital Universitario Central de Asturias
Laboratorio de Genética
SPAIN
Murcia
EL PALMAR
Characterization of arrhythmogenic cardiomyopathy from zebrafish models and development of gene therapy
IMIB - Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca
Grupo de investigación en Cardiología Clínica y Experimental
SWEDEN
Region Västerbotten
UMEÅ
Familial long QT syndrome and familial hypertrophic cardiomyopathy in Sweden: clinical, molecular, genetic and experimental studies
University Hospital of Umeå
Department of Public Health and Clinical Medicine
UNITED KINGDOM
Aberdeen
ABERDEEN
Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy (GENETIC)
University of Aberdeen
University of Aberdeen HQ
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
TRAM2: TTR Screening - Screening for Hereditary Transthyretin Related Amyloidosis - an International, Multicentre, Epidemiological Protocol - AT
Institution: Information not provided - AT
FRANCE
ILE-DE-FRANCE
PARIS
Genomic editing by CRISPR / Cas9 to treat cardiomyopathies linked to mutations in the LMNA gene
Institut de Myologie - Hôpital Pitié-Salpêtrière
Centre de Recherche en Myologie
GERMANY
Baden-Württemberg
HEIDELBERG
ReDox: Repurposing doxycycline in the treatment of AL amyloidosis - DE
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie
GERMANY
Schleswig-Holstein
KIEL
Role of microRNA-582 in cardiac signal transduction, hypertrophy and heart failure
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Klinik für Innere Medizin III - Kardiologie, Angiologie und internistische Intensivmedizin
JAPAN
JAPAN
OSAKA
The combination of clinical and basic research about peripartum cardiomyopathy to develop the novel biomarkers and treatment
National Cerebral and Cardiovascular Center
Division of Obstetrics and Gynecology
JAPAN
JAPAN
OSAKA
Investigation of clinical index for stratifying phenotypes of cardiomyopathy with newly developed nuclear chromatin assessment
Osaka University Graduate School of Medicine
Department of Cardiovascular Medicine
SWITZERLAND
Suisse Alémanique
BERN
ATTR Amyloidosis in Elderly Patients With Aortic Stenosis
University Hospital Inselspital
Universitätsklinik für Kardiologie
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Diabetic pregnancies and gastrulation
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Epigenetic mechanisms in diabetic embryopathy
Institution: Information not provided - US
AUSTRIA
TIROL
INNSBRUCK
TTRACK: Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology - AT
Medizinische Universität Innsbruck
Universitätsklinik für Innere Medizin III - Kardiologie und Angiologie
FRANCE
ILE-DE-FRANCE
PARIS
Analysis of cardiac phenotype and underlying genotype in glycogen storage disease type 2B
APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière
Départements de génétique et de cardiologie - Centre de référence des maladies cardiaques héréditaires
GERMANY
Baden-Württemberg
ULM
GeNeRARe: German Network for RASopathies
Institute of Comparative Molecular Endocrinology der Universität Ulm
Cirstea Lab
GERMANY
Hamburg
HAMBURG
GeNeRARe: German Network for RASopathies
UKE - Universitätsklinikum Hamburg-Eppendorf
Institut für Humangenetik
GERMANY
Niedersachsen
GÖTTINGEN
GeNeRARe: German Network for RASopathies
Universitätsmedizin Göttingen
Klinik für Thorax-, Herz- und Gefäßchirurgie
GERMANY
Nordrhein-Westfalen
DÜSSELDORF
GeNeRARe: German Network for RASopathies
Heinrich-Heine-Universität Düsseldorf
Institut für Biochemie und Molekularbiologie II
GERMANY
Sachsen-Anhalt
MAGDEBURG
GeNeRARe: German Network for RASopathies
Otto-von-Guericke-Universität Magdeburg
Abteilung Genetik & Molekulare Neurobiologie
ITALY
CAMPANIA
CASERTA
TTR-FAP Italian Registry: a collaborative network for definition of natural history, psychosocial burden, standards of care and clinical trials
Università degli Studi della Campania Luigi Vanvitelli
Dipartimento di Psicologia
ITALY
LAZIO
ROMA
Clinical and molecular characterization of genetic syndromes with congenital heart disease
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE SAN PAOLO
U.O.C. Laboratorio di Genetica Medica
JAPAN
JAPAN
MIYAGI
Pathogenesis and novel therapeutic approarches in RASoapthies
Tohoku University School of Medicine
Department of Medical Genetics
PORTUGAL
NORTE
PORTO
Dissecting nerve regeneration and the neuritogenic activity of TTR
Instituto de Biologia Molecular e Celular
Nerve Regeneration Group
PORTUGAL
NORTE
PORTO
Phenotypic variability and modifier genes in Familial Amyloid Polyneuropathy (FAP ATTRV30M)
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas
PORTUGAL
NORTE
PORTO
Therapies in familial amyloidotic polyneuropathy
Instituto de Biologia Molecular e Celular
Unidade de Neurobiologia Molecular
PORTUGAL
NORTE
PORTO
Molecular basis of nervous system dysfunction on amyloid neuropathies
Instituto de Biologia Molecular e Celular
Unidade de Neurobiologia Molecular
PORTUGAL
SUL
LISBOA
TTR amyloid fibril formation in vivo - Looking beyond genetic factors
Faculdade de Ciências da Universidade de Lisboa
Laboratório de Enzimologia
SPAIN
Madrid
MAJADAHONDA
Characterization and early detection of atrial arrhythmias and conduction disorders in transthyretin cardiac amyloidosis
Hospital Universitario Puerta de Hierro - Majadahonda
Servicio de Cardiopatías Familiares
SWEDEN
Region Västerbotten
UMEÅ
Mechanistic and structural elucidation of amyloid and its cytotoxic propensity
Umeå University
Department of medical biochemistry and biophysics
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Direct regulation of extracellular proteostasis by the unfolded protein response
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Use of rapamycin for the treatment of hypertrophic cardiomyopathy in patients with leopard syndrome
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Solid-state nmr structural characterizations of polymorphic transthyretin amyloids
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Signaling pathways regulating oligodendrocyte development and function
Institution: Information not provided - US
Multicentric Research projects
- CHU Paris IdF Ouest - HEGP Hôpital Européen Georges Pompidou
- Thérapie cellulaire en pathologie cardiovasculaire
- Fondazione IRCCS Policlinico San Matteo
- Laboratorio di Diagnostica Molecolare, Patologia Cardiovascolare e dei Trapianti
- John Radcliffe Hospital
- Department of Cardiovascular Medicine
- Fondazione IRCCS Policlinico San Matteo
- Dipartimento di Medicina Molecolare
- Department of Health
FRANCE
ILE-DE-FRANCE
PARIS
CaPTAA: Cardiac Progenitors TransAtlantic Alliance
ITALY
LOMBARDIA
PAVIA
INHERITANCE: INtegrated HEart Research In TrANslational genetics of dilated Cardiomyopathies in Europe (TERMINATED)
UNITED KINGDOM
Oxfordshire
OXFORD
BIG-HEART: bench-to-beside integrated approach to familial hypertrophic cardiomyopathy: to the heart of the disease (coordination)
ITALY
LOMBARDIA
PAVIA
ReDox : Repurposing doxycycline in the treatment of AL amyloidosis
UNITED KINGDOM
Greater London
LONDON